Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listin...(TCQX International Market under the symb...),Health
Navigation Links
Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF
Date:6/23/2009
TCQX International Market under the symbol "HXBPF".
About Merriman Curhan Ford
Merriman Curhan Ford (Nasdaq: MERR) is a financial services firm focused on fast-growing companies and the institutions that invest in them. The company offers high-quality investment banking, equity research, institutional services and corporate & venture services, and specializes in five growth industry sectors: CleanTech, Consumer/Internet/Media, Health Care, Natural Resources and Technology. For more information, please go to www.mcfco.com.
About OTCQX
The OTCQX marketplace, operated by Pink OTC Markets Inc., is the premier tier of the U.S. over-the-counter market. OTCQX provides a gateway to U.S. securities markets for international companies that are listed on a qualified non-U.S. exchange and provide ongoing disclosure in English to U.S. investors. More importantly, OTCQX distinguishes the reputable international issuers from the 9,000 over-the-counter securities traded in the U.S. Only leading companies that have substantial operating businesses and provide credible disclosure to the public are eligible for inclusion on the premium-tier OTCQX, which commenced trading on March 5, 2007. For more about OTCQX, visit www.otcqx.com.
For further information contact:
Investor & Media Relations
Ian Stone
Russo Partners LLC
Tel: (619) 814-3510
Fax: (619) 955-5318
Email: ian.stone@russopartnersllc.com
Robert Flamm, Ph.D.
Russo Partners LLC
Tel: (212) 845-4226
Email: robert.flamm@russopartnersllc.com
www.russopartnersllc.co
'/>"/>
| SOURCE Helix BioPharma Corp. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update
2. CSL Behrings Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance
3. Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its Tai Drug Series
4. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
5. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
6. PDL BioPharma Announces Record Date for October 1 Dividend Payment
7. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
8. SAFE-BioPharma Webinar Featuring ARX's Digital Signatures Combined with Microsoft SharePoint for Bio-Pharma industry
9. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
10. The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate
11. SAFE-BioPharma Webinar Featuring ARX's Digital Signature Solution and Adobe LiveCycle Combined Solution
Post Your Comments:
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Dental tourism is a phenomenon that was started by people that were looking for an alternative to the high price of dental work in the US, Canada, and other countries. In their search for lower priced
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
(Date:12/4/2009)Research and surveillance urged for at-risk patient groups , , FRIDAY, Dec. 4 (HealthDay News) -- Some childhood cancers, particularly Ewing sarcomas and central nervous system tumors, carry t
Breaking Medicine News(10 mins):Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2[0] News brief -- childhood cancer survivor study report: Late recurrence is a risk for some cancers[0] Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week'[0] Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor [0] Makers of Powerful Painkillers Present Safety Plans [0] Certain Childhood Cancers More Likely to Recur
...w insights into the role of estrogen receptor in m...r understand the molecular origin of breast cancer... Cincinnati (UC). , About a decade ago, U.S. sci...ors role in human diseases. , Unfortunately, beca...
...N, Sept. 5 On Friday, August 31, 2007, the First,... lawsuit brought by Maine,residents against Philip...ument that the claims were preempted by federal la...lleging that,Philip Morris, USA, Inc., and its par...
... Nurses Fight Healthcare Takeaways, Win Better Pat...nd Pay 10,000 CHW RNs in 25 Facilities Set to B... Some 3,500 registered nurses,at nine Southern Ca...urses Association announced today. The agreement,...
... children of affected Holocaust survivors showed h...(HealthDay News) -- Adults whose mother or father ...) often experience the biological signs of PTSD th...rvivors with PTSD. , A team of researchers from t...
...veries could lead to new treatments for autoimmune...ept. 5 (HealthDay News) -- Two genes boost the ris... also increases the odds for lupus, according to t...atoid arthritis or lupus, both of which are autoim...
...N, Va., Sept. 5 The National Association for Spor... today announced a new,partnership to help to educ...lop the knowledge, skills and attitudes for a heal...omoting this,comprehensive health-related fitness ...
Other Medicine News:Health News:New 'knock-out' gene model provides molecular clues to breast cancer 2Health News:New 'knock-out' gene model provides molecular clues to breast cancer 3Health News:First Circuit Court of Appeals Rules Against Philip Morris in 'Lights' Class Action 2Health News:RNs at Nine Catholic Healthcare West Hospitals Reach Agreement on New Master Pact 2Health News:Parents' PTSD May Boost Stress in Offspring 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 3Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 4Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 2Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 3New 'knock-out' gene model provides molecular clues to breast cancerFirst Circuit Court of Appeals Rules Against Philip Morris in 'Lights' Class ActionRNs at Nine Catholic Healthcare West Hospitals Reach Agreement on New Master PactParents' PTSD May Boost Stress in OffspringGenes Boost Risk for Rheumatoid Arthritis, LupusNational Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Signatec Unveils PX14400 Its High Speed PCI Express Digitizer Capable of Sustained Recordings Over 1 2 GB s with Xilinx Virtex 5 FPGAs for Embedded R 14041 1Signatec Unveils PX14400 Its High Speed PCI Express Digitizer Capable of Sustained Recordings Over 1 2 GB s with Xilinx Virtex 5 FPGAs for Embedded R 14041 2Signatec Unveils PX14400 Its High Speed PCI Express Digitizer Capable of Sustained Recordings Over 1 2 GB s with Xilinx Virtex 5 FPGAs for Embedded R 14041 3Signatec Unveils PX14400 Its High Speed PCI Express Digitizer Capable of Sustained Recordings Over 1 2 GB s with Xilinx Virtex 5 FPGAs for Embedded R 14041 4STEMCELL Technologies Applauds Feeder free Derivation of Human Induced Pluripotent Stem Cells 57142 1STEMCELL Technologies Applauds Feeder free Derivation of Human Induced Pluripotent Stem Cells 57142 2AirMed Asia has Entered into a Joint Venture Agreement with Asia Air Medical to Expand Air Medical Transport in China 57137 1AirMed Asia has Entered into a Joint Venture Agreement with Asia Air Medical to Expand Air Medical Transport in China 57137 2[0] Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial[0] Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker[0] Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7
...y and,worldwide leader in radiation treatment plan...unced that three sites have delivered clinical,tre...Intensity Modulated,Radiotherapy (IMRT) treatment ...tsburgh, Pennsylvania, Erasmus Medical Center in R...ran Hospital in Milwaukee,Wisconsin, have all begu...
...studies of immunosuppression in kidney transpla...OLUMBIA, Md., Aug. 28 "Cylex, Inc., in associatio... delighted to be able to,announce our support for ...for cell-mediated immunity at seven highly respect... stated Brad Stewart, president of Cylex. "It is,a...
Other Medicine Technology:CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System 2Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 2Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 3...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |